Inequality in healthcare R&D outcomes: a model of process disruption

References

• Allegranzi, B, Nejad, SB, Combescure, C, Graafmans, W, Attar, H, Donaldson, L & Pittet, D, 2011. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. The Lancet 377(9761), 228–41. doi: 10.1016/S0140-6736(10)61458-4
   PubMed Web of Science ®Google Scholar
• Bernstein, A, Klein, M & Malone, TW, 2012. Programming the global brain. Communications of the ACM 55(5), 41–3. doi: 10.1145/2160718.2160731
   Web of Science ®Google Scholar
• Bonney, R, Cooper, CB, Dickinson, J, Kelling, S, Phillips, T, Rosenberg, KV & Shirk, J, 2009. Citizen science: A developing tool for expanding science knowledge and scientific literacy. BioScience 59(11), 977–84. doi: 10.1525/bio.2009.59.11.9
   Web of Science ®Google Scholar
• Callaghan, CW, 2015. Crowdsourced R&D and medical research. British Medical Bulletin 115(1), 67–6. doi: 10.1093/bmb/ldv035
   PubMed Web of Science ®Google Scholar
• Callaghan, CW, 2016. Citizen science and biomedical research: Implications for bioethics theory and practice. Implications for bioethics theory and practice. Informing Science: The International Journal of an Emerging Transdiscipline 19, 325–343. doi: 10.28945/3579
   Google Scholar
• Callaghan, CW, 2017. The knowledge aggregation problem: Shaping the new research agenda. British Academy of Management Conference, University of Warwick, 5–7 September, United Kingdom.
   Google Scholar
• Callaghan, CW, 2018. Surviving a technological future: Technological proliferation and modes of discovery. Futures 104, 100–16. doi: 10.1016/j.futures.2018.08.001
   PubMed Web of Science ®Google Scholar
• Chesbrough, H, 2011. Pharmaceutical innovation hits the wall: How open innovation can help. Forbes. https://www.forbes.com/sites/henrychesbrough/2011/04/25/pharmaceutical-innovation-hits-the-wall-how-open-innovation-can-help/#71b20c6e68af.
   Google Scholar
• Deaton, A. 2011. What does the empirical evidence tell us about the injustice of health inequalities? https://dc-20788-1635065795.us-east-1.elb.amazonaws.com/system/files/research/documents/deaton_what_does_the_empirical_evidence_tell_us_about_the_injustice_of_health_inequalities.pdf.
   Google Scholar
• Fenton, E, Chillag, K & Michael, NL, 2015. Ethics preparedness for public health emergencies: Recommendations from the Presidential Bioethics Commission. The American Journal of Bioethics 15, 77–9. doi: 10.1080/15265161.2015.1054162
   PubMed Web of Science ®Google Scholar
• Fidler, DP, 1998. Legal issues associated with antimicrobial drug resistance. Emerging Infectious Diseases 4(2), 169–77. doi: 10.3201/eid0402.980204
   PubMed Web of Science ®Google Scholar
• Foster, RN, 1985. Timing technological transitions. Technology in Society 7, 127–41. doi: 10.1016/0160-791X(85)90022-3
   Web of Science ®Google Scholar
• Funtowicz, SO & Ravetz, JR, 1994. Uncertainty, complexity and post-normal science. Environmental Toxicology and Chemistry 13(12), 1881–5. doi: 10.1002/etc.5620131203
   Web of Science ®Google Scholar
• Grasela, TH & Slusser, R, 2014. The paradox of scientific excellence and the search for productivity in pharmaceutical research and development. Clinical Pharmacology & Therapeutics 95(5), 521–7. doi: 10.1038/clpt.2013.242
   PubMed Web of Science ®Google Scholar
• Harbarth, S, Theuretzbacher, U, Hackett, J, DRIVE-AB consortium, Adriaenssens, N, Anderson, J, … & Bettiol, E, 2015. Antibiotic research and development: Business as usual?. Journal of Antimicrobial Chemotherapy 70(6), 1604–7.
   PubMed Web of Science ®Google Scholar
• Hayek, FA, 1945. The use of knowledge in society. The American Economic Review 35(4), 519–30.
   Web of Science ®Google Scholar
• Hottenrott, H, Hall, BH, & Czarnitzki, D, 2016. Patents as quality signals? The implications for financing constraints on R&D. Economics of Innovation and New Technology 25(3), 197–217. doi: 10.1080/10438599.2015.1076200
   Web of Science ®Google Scholar
• Huttner, A, Harbarth, S, Carlet, J, Cosgrove, S, Goossens, H, Holmes, A, Jarlier, V, Voss, A & Pittet, D, 2013. Antimicrobial resistance: A global view from the 2013 World Healthcare-Associated Infections Forum. Antimicrobial Resistance and Infection Control 2(1), 31. doi: 10.1186/2047-2994-2-31
   PubMed Web of Science ®Google Scholar
• Jeppesen, LB, & Lakhani, KR, 2010. Marginality and problem-solving effectiveness in broadcast search. Organization Science 21(5), 1016–33. doi: 10.1287/orsc.1090.0491
   Web of Science ®Google Scholar
• Jones, BF, 2009. The burden of knowledge and the death of the renaissance man: Is innovation getting harder? Review of Economic Studies 76, 283–317. doi: 10.1111/j.1467-937X.2008.00531.x
   Web of Science ®Google Scholar
• Kaitin, KI, 2010. Deconstructing the drug development process: The new face of innovation. Clinical Pharmacology and Therapeutics 87(3), 356–61. doi: 10.1038/clpt.2009.293
   PubMed Web of Science ®Google Scholar
• Kortum, S, 1997. Research, patenting, and technological change. Econometrica 65(6), 1389–419. doi: 10.2307/2171741
   Web of Science ®Google Scholar
• Kuhn, TS, 1970. The structure of scientific revolutions. 2nd edn. University of Chicago Press, Chicago.
   Google Scholar
• Kumarasamy, KK, Toleman, MA, Walsh, TR, Bagaria, J, Butt, F, Balakrishnan, R, Chaudhary, U, Doumith, M, Giske, CG, Irfan, S, Krishnan, P, Kumar, AV, Maharjan, S, Mushtaq, S, Noorie, T, Paterson, DL, Pearson, A, Perry, C, Pike, R, Rao, B, Ray, U, Sarma, JB, Sharma, M, Sheridan, E, Thirunarayan, MA, Turton, J, Upadhyay, S, Warner, M, Welfare, W, Livermore, DM & Woodford, N, 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. The Lancet Infectious Diseases 10(9), 597–602. doi: 10.1016/S1473-3099(10)70143-2
   PubMed Web of Science ®Google Scholar
• Malone, TW, Laubacher, R, & Dellarocas, C, 2009. Harnessing crowds: Mapping the genome of collective intelligence. (MIT Sloan School Working Paper No. 4732-09). https://dspace.mit.edu/bitstream/handle/1721.1/66259/SSRN-id1381502.pdf?sequence=1/ Accessed 29 October 2017.
   Google Scholar
• Munos, B, 2009. Lessons from 60 years of pharmaceutical innovation. Nature Reviews Drug Discovery 8(12), 959–68. doi: 10.1038/nrd2961
   PubMed Web of Science ®Google Scholar
• Nathan, C, 2007. Aligning pharmaceutical innovation with medical need. Nature Medicine 13(3), 304–8. doi: 10.1038/nm0307-304
   PubMed Web of Science ®Google Scholar
• Nickerson, JA & Zenger, TR, 2004. A knowledge-based theory of the firm—the problem-solving perspective. Organization Science 15(6), 617–32. doi: 10.1287/orsc.1040.0093
   Web of Science ®Google Scholar
• Nielsen, M, 2012. Reinventing discovery. Princeton University Press, Princeton.
   Google Scholar
• Nonaka, I, 1994. A dynamic theory of organizational knowledge creation. Organization Science 5(1), 14–37. doi: 10.1287/orsc.5.1.14
   Web of Science ®Google Scholar
• Outterson, K, 2005. The vanishing public domain: antibiotic resistance, pharmaceutical innovation and intellectual property law. University of Pittsburgh Law Review 67, 67–123. doi: 10.5195/LAWREVIEW.2005.70
   Web of Science ®Google Scholar
• Polanyi, M, 1973. Personal knowledge: toward a post-critical philosophy. Routledge & Kegan Paul, London.
   Google Scholar
• Romer, PM, 1990. Endogenous technological change. Journal of Political Economy 98(5), S71–102. doi: 10.1086/261725
   Web of Science ®Google Scholar
• Segerstrom, PS, 1997. Endogenous growth without scale effects. The American Economic Review 88(5), 1290–310.
   Web of Science ®Google Scholar
• Scannell, JW, Blanckley, A, Boldon, H & Warrington, B, 2012. Diagnosing the decline in pharmaceutical R&D efficiency. Nature Reviews Drug Discovery 11(3), 191–200. doi: 10.1038/nrd3681
   PubMed Web of Science ®Google Scholar
• Shirk, JL, Ballard, HL, Wilderman, CC, Phillips, T, Wiggins, A, Jordan, R, McCallie, E, Minarchek, M, Lewenstein, BV, Krasny, ME, & Bonney, R, 2012. Public participation in scientific research: A framework for deliberate design. Ecology and Society 17(2), 1–29. doi: 10.5751/ES-04705-170229
   Web of Science ®Google Scholar
• Tegmark, M, 2017. Life 3.0. Being human in the age of artificial intelligence. Penguin, London.
   Google Scholar
• Trouiller, P, Olliaro, P, Torreele, E, Orbinski, J, Laing, R & Ford, N, 2002. Drug development for neglected diseases: A deficient market and a public-health policy failure. The Lancet 359(9324), 2188–94. doi: 10.1016/S0140-6736(02)09096-7
   PubMed Web of Science ®Google Scholar
• Vayena, E & Tasioulas, J, 2013. The ethics of participant-led biomedical research. Nature Biotechnology 31(9), 786–87. doi: 10.1038/nbt.2692
   PubMed Web of Science ®Google Scholar
• Wagstaff, A, 2002. Poverty and health sector inequalities. Bulletin of the World Health Organization 80, 97–105.
   PubMed Web of Science ®Google Scholar
• Weitzman, ML, 1998. Recombinant growth. The Quarterly Journal of Economics 113(2), 331–60. doi: 10.1162/003355398555595
   Web of Science ®Google Scholar